Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca_logo_building

AstraZeneca’s drug scores positive results against chemo in breast cancer

February 17, 2017
Medical Communications, Research and Development AstraZeneca

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …

News

NICE turns down AZ’s chronic obstructive pulmonary disease drug

February 13, 2017
Sales and Marketing AstraZeneca, Daxas, NICE, chronic obstructive pulmonary disease

AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), …

News

AZ to rework ongoing immuno-oncology trials to “enhance options”

January 17, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, non-small cell lung cancer

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …

News
merck_and_co

MSD looks to jump the gun with combination immunotherapy application

January 11, 2017
Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …

News
astrazeneca_sign_sky

AstraZeneca acquires biotech’s unique antithrombotic drug

January 5, 2017
Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition

AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …

News

Pfizer announces acquisition of small-molecule business from AZ for $550 million

December 23, 2016
Medical Communications AstraZeneca, Pfizer

Pfizer has announced that they have acquired AstraZeneca’s small molecule anti-infectives business for an upfront fee of $550 million. Pfizer …

News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 21, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

Appointment

AstraZeneca opens £120 million UK manufacturing facility

December 20, 2016
Manufacturing and Production AstraZeneca, Macclesfield

AstraZeneca has officially opened a new manufacturing facility for cancer medicines based in Macclesfield, UK. It becomes the second largest …

News
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 19, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016
Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …

News
shutterstock_92671375

Five major pharma firms break ABPI code of conduct, according to watchdog

December 15, 2016
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Grunenthal, Janssen

Eli Lilly, Boehgringer Ingelheim, AstraZeneca UK, Grunenthal and Janssen-Cilag have been “named and shamed” by the Prescription Medicines Code of …

News
astrazeneca_plaque

AZ to terminate 700 US jobs

December 9, 2016
Manufacturing and Production, Medical Communications AstraZeneca, job cuts

AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …

News
astrazeneca_sign_sky

AZ lung cancer drug cuts disease progression by 70%

December 7, 2016
Research and Development AstraZeneca, Tagrisso

AstraZeneca is touting its cancer drug Tagrisso (osimertinib) as a potential new standard of care for epidermal growth factor receptor …

News
astrazeneca_building_white

AstraZeneca seals $1 billion deal with Bicycle Therapeutics

December 2, 2016
Medical Communications, Sales and Marketing AstraZeneca, Bicycle Therapeutics

Bicycle Therapeutics, Cambridge-based British biotech firm, has announced that it has signed a deal that could potentially be worth over …

News

GSK reaches endgame of race to develop anaemia drug

November 25, 2016
Research and Development, Sales and Marketing AstraZeneca, Daprodustat, GSK, GlaxoSmithKline, anaemia

GlaxoSmithKline has announced that they will begin Phase 3 development of their anaemia drug, daprodustat. The drug is an oral …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025